Trade ATOS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Atossa Therapeutics, Inc. (ATOS) is trading at US$2.52, down 4.55% today as of Aug 28, 12:20 EDT. The company has a market capitalisation of US$25.35M. Over the past 52 weeks, ATOS has traded between US$1.70 and US$19.35. On Syfe you can trade ATOS with $0 commission and add it to your watchlist.
| Previous close | US$2.64 |
|---|---|
| Market cap | US$25.35M |
| 52-week range | US$1.70 – US$19.35 |
| Volume | 23.11K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Year: 2012
Top Midday Decliners
Jun 11, 5:47 PM · MT Newswires
Atossa Therapeutics Launches $16.5 Million Registered Direct Offering
Jun 11, 12:39 PM · MT Newswires
Atossa Therapeutics, Inc. (ATOS) stock is trading at US$2.52, -4.55% from the previous close of US$2.64.
The market cap for Atossa Therapeutics, Inc. (ATOS) stock is approximately US$25.35M.
The 52-week high for Atossa Therapeutics, Inc. (ATOS) stock is US$19.35.
The 52-week low for Atossa Therapeutics, Inc. (ATOS) stock is US$1.70.
Atossa Therapeutics, Inc. (ATOS) does not currently pay a dividend.
Stay on top of ATOS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
